Products

Millions of patients—billions of allergies
One in five people suffers from allergic disease or allergy-induced asthma—over 50 million in the United States alone. The proprietary MAST (Multiple Antigen Simultaneous Test) technology is the most efficient and cost-effective way for physicians to measure a patient's sensitivity to many allergens at once.

This affordable, compact and flexible system requires only a single test, allowing physicians to save time, reduce costs, and diagnose patients quickly and more precisely. Unlike skin-prick tests, MAST technology is quantifiable and objective; and it requires only one blood sample, making it less invasive to the patient. By delivering rapid diagnosis, the safe and reliable MAST system enables allergy sufferers to begin therapy more quickly.

The foundations of this innovative technology are the patented MASTpette and CLA-1 Luminometer.

MASTpette®

The fundamental component of the system is the MASTpette, a small plastic device that can measure the severity of a patient's allergic reaction to 36 different substances, all using a single blood sample.

Extensive variety of allergens to serve every patient's unique needs
MAST serves allergy patients worldwide—so every MASTpette is geographically specific. Physicians can choose a food panel, which contains some of the most common ingested allergens, such as milk, tomato, soybean, or wheat; an inhalant panel, which tests for sensitivity to pollen, dust, mites, and other airborne allergens in the patient's area; or a combination panel, which includes the 36 most prevalent food and inhalant allergens overall. To fulfill an individual patient's needs, physicians can also request custom panels, choosing from a broad palette of available allergens.

Inside every MASTpette are 36 segments of organic threads, each containing a selected allergen. The patient's blood sample is drawn into the device, and proteins in the blood bind to those threads that trigger an allergic reaction. The physician then adds a secondary compound to the panel, which causes the threads to produce light in varying strengths, depending on the intensity of the allergic response. The results are determined by loading the MASTpette into the CLA-1 Luminometer. Alternatively, physicians can simply send a patient's blood sample to the MAST Allergy Testing Service laboratory for analysis.

CLA-1 Luminometer

Fast, accurate analysis
Counterpart to the MASTpette, the CLA-1 Luminometer completes the allergy testing process. This state-of-the-art patented device reads prepared MASTpette panels, measuring the intensity of the signal emitted by each segment of allergen threads. In a brief eight minutes, it can analyze up to 180 allergens!

The compact CLA-1 Luminometer automatically prints a complete report that lists the tested allergens and the severity of the patient's response to each. Profoundly easy to use and understand, the system is the simplest, quickest and most convenient allergy testing method available today.

Self-testing for reliability
To ensure correct test results, the instrument performs a self-diagnostic check each time it is powered up, and clearly displays system status on its digital screen. The CLA-1 Luminometer is FDA approved, and has shown consistent performance and accuracy in laboratories around the world.

Data Management Software (DMS)

Comprehensive patient data at your fingertips
Physicians can also choose to integrate database functionality into the testing process, using the CLA-1 Data Management Software. This Windows application features a clear interface that allows users to enter patient information, order tests, and receive operating instructions for the CLA-1 device. The powerful software also records patient data and test results, giving physicians easy access to complete patient histories, and eliminating repetitive data entry.

MAST technology is

efficient • convenient • cost-effective • less invasive • versatile • simple • objective • precise • easy to use • preferred by patients • fast • reliable • available now

...in every way, an unrivaled approach to the rapid diagnosis and treatment of allergy patients around the globe.


Next:

• Services
• Corporate Overview

Back to Top